Secondary polycystic ovarian: treatment (case report)

Abstract

Hyperandrogenism in women as hyperandrogenism pathomorphism and polycystic ovary syndrome is believed to be one of the worth pathologies of our time. In the structure of polycystic ovaries, 80% of cases account to a secondary polycystic ovaries. The reason for writing the article was a clinical case of patient N with a diagnosis: Chronic autoimmune thyroiditis, atrophic form, decompensated hypothyroidism moderate. Normogonadotropic hypogonadism. Secondary amenorrhea. Hyperandrogenism (presumably ovarian dysfunction). Secondary polycystic ovaries. Because of taking into account the clinical laboratory and the patient’s personal characteristics, the correction of treatment was made: 1. Levothyroxine 50 mcg per day. 2. Flutamide (Flutafarm, produced by Farmak) 125 mg three times a day. The patient was well tolerated to the treatment. The menstrual cycle was relatively regular - 27-32 days. Monthly follicle count was done. Ovulation was confirmed with pelvic ultrasound on the 4th month of treatment with Flutafarm.